EUVIMEDEUVIMED entdecken
Open Access

Barriers to Clinical Trial Implementation Among Community Care Centers

Hedyeh Ebrahimi, Sandra Megally, Elana Plotkin, Latha Shivakumar, Nicholas J Salgia, Zeynep B Zengin, Luis Meza, Neal Chawla, Daniella V Castro, Nazli Dizman, Ruma Bhagat, Seila Liv und 9 weitere

JAMA Network Open · 29.04.2024 · 7 (4) · e248739

DOI: 10.1001/jamanetworkopen.2024.8739 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 29.04.2024. Verfasst von Hedyeh Ebrahimi und 20 weiteren Autor:innen. Beteiligte Einrichtung: City of Hope Comprehensive Cancer Center, Duarte, California. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance While an overwhelming majority of patients diagnosed with cancer express willingness to participate in clinical trials, only a fraction will enroll onto a research protocol.

Objective

To identify critical barriers to trial enrollment to translate findings into actionable practice changes that increase cancer clinical trial enrollment. Design, Setting, and Participants This survey study included designated site contacts at oncology practices with teams who were highly involved with the Association of Community Cancer Centers (ACCC) Community Oncology Research Institute (ACORI) clinical trials activities, all American Society of Clinical Oncology (ASCO)–ACCC collaboration pilot sites, and/or sites providing care to at least 25% African American and Hispanic residents. To determine participation trends among health care practices in oncology-focused research, identify barriers to clinical trial implementation and operation, and establish unmet needs for cancer clinics interested in trial participation, a 34-question survey was designed. Survey questions were defined within 3 categories: cancer center demographic characteristics, clinical trial characteristics, and referral practices. The survey was distributed through email and was open from June 20 through October 5, 2022. Main Outcomes and Measures Participation in and barriers to conducting oncology trials in different community oncology settings.

Results

The survey was distributed to 100 cancer centers, with completion by 58 centers (58%) across 25 states. Fifty-two centers (88%) reported that they conduct therapeutic clinical trials, of which 33 (63%) were from urban settings, 11 (21%) were from suburban settings, and 8 (15%) were from rural settings. Only 25% of rural practices (2 of 8) offered phase 1 trials, compared with 67% of urban practices (22 of 33) ( P = .01). Respondents noted challenges in conducting research, including patient recruitment (27 respondents [52%]), limited staffing (27 [52%]), and nonrelevant trials for their patient population (25 [48%]). Among sites not offering therapeutic trials, barriers to research conduct included limited infrastructure, funding, and staffing. Most centers (46 of 58 [79%]) referred patients to outside centers for clinical trial enrollment, particularly in the context of late-stage disease and/or disease progression. Only 17 of these sites (37%) had established protocols for patient follow-up subsequent to outside referral. Conclusions and Relevance In this national survey study of barriers to clinical trial implementation, most sites offered therapeutic trials, but there were significant disparities in trial availability across care settings. Furthermore, fundamental deficiencies in trial support infrastructure limited research activity, including within programs currently conducting research as well as at sites interested in future clinical research opportunities. These results identify crucial unmet needs for oncology clinics to effectively offer clinical trials to patients seeking care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicHumansSurveys and QuestionnairesNeoplasmsPatient SelectionCommunity Health CentersUnited StatesCancer Care FacilitiesFemale

Autor:innen und Institutionen

  • City of Hope Comprehensive Cancer Center, Duarte, California.
  • Association of Community Cancer Centers, Rockville, Maryland.
  • Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
  • Department of Internal Medicine, MD Anderson Cancer Center, Houston, Texas.
  • Genentech, Inc, South San Francisco, California.

Förderung

  • NCI NIH HHS

Zitieren

APA

Ebrahimi, H., Megally, S., Plotkin, E., Shivakumar, L., Salgia, N. J., Zengin, Z. B., Meza, L., Chawla, N., Castro, D. V., Dizman, N., Bhagat, R., Liv, S., Li, X., Rock, A., Liu, S., Tripathi, A., Dorff, T., Oyer, R. A., Boehmer, L., …, & Chehrazi-Raffle, A. (2024). Barriers to Clinical Trial Implementation Among Community Care Centers. JAMA Network Open, 7(4), e248739. https://doi.org/10.1001/jamanetworkopen.2024.8739

Vancouver

Ebrahimi H, Megally S, Plotkin E, Shivakumar L, Salgia NJ, Zengin ZB, et al. Barriers to Clinical Trial Implementation Among Community Care Centers. JAMA Network Open. 2024;7(4):e248739. doi:10.1001/jamanetworkopen.2024.8739

BibTeX
@article{Ebrahimi2024,
  author = {Ebrahimi, Hedyeh and Megally, Sandra and Plotkin, Elana and Shivakumar, Latha and Salgia, Nicholas J and Zengin, Zeynep B and Meza, Luis and Chawla, Neal and Castro, Daniella V and Dizman, Nazli and Bhagat, Ruma and Liv, Seila and Li, Xiaochen and Rock, Adam and Liu, Sandy and Tripathi, Abhishek and Dorff, Tanya and Oyer, Randall A and Boehmer, Leigh and Pal, Sumanta and Chehrazi-Raffle, Alexander},
  title = {Barriers to Clinical Trial Implementation Among Community Care Centers},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {4},
  pages = {e248739},
  doi = {10.1001/jamanetworkopen.2024.8739}
}
Kostenlos starten →